Device Trial Radar · NCT00805948
Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)
Last checked: Nov 20, 2026Latest source record: Sep 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
349
Actual
Start
Apr 2009
Primary completion
Aug 2016
Study completion Aug 2017
Sponsor
- Lead sponsor
- Medtronic CardiovascularPublic (MDT)
- Sponsor type
- Industry
- Collaborators
- Medtronic
- First posted
- Dec 10, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.
Conditions
- Thoracic Aortic Aneurysms
Interventions
Talent Thoracic Stent Graft SystemDevice
endovascular repair of descending thoracic aortic aneurysms using the Talent Thoracic Stent Graft System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom From Aneurysm-related Mortality at 5 YearsTime frame: 5 years
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Cedars Sinai Medical Center
Los Angeles, California
Harbor-UCLA
Torrance, California
Washington Hospital D.C.
Washington D.C., District of Columbia
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.